查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1596185

监管事务市场：按服务、按适应症、按阶段、按类别、按服务供应商、按公司规模、按最终用户 - 2025-2030 年全球预测

Regulatory Affairs Market by Services, Indication, Stage, Category, Service Provider, Company Size, End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年监管事务市场价值为156.3亿美元，预计到2024年将达到172.2亿美元，复合年增长率为10.63%，预计到2030年将达到317.1亿美元。

市场研究领域的监管事务范围包括遵守保护公众健康和安全的法律法规、监督产品生命週期管理，医疗设备包括核准和註册便利。监管事务的需要是保护公共利益、降低风险、维护市场进入，同时提高企业信誉。该领域的应用范围从产品开发早期阶段的策略建议到上市后监督和监管提交。最终用途范围涵盖产品功效、安全性和合规性领域。关键的成长要素包括不断变化的监管环境、不断增加的产品复杂性以及促进跨境市场渗透的全球化。数位化的快速进步为自动化和人工智慧简化监管流程铺平了道路，为公司提供了缩短上市时间、同时提高合规准确性的新机会。然而，这些进步也带来了挑战，例如需要跟上不断变化的全球法规以及满足不同合规要求相关的高成本。为了保持竞争力，公司必须在收集和分析监管资料、采用预测分析和利用数位转型方面进行创新。公司应透过投资提高资料透明度的技术、与相关人员建立积极的合作伙伴关係以及采用敏捷的监管提交方法来抓住潜在的机会。我们还可以透过专注于建立强大的系统来促进创新，这些系统提供即时监管资讯和见解，彻底改变风险评估和决策流程。儘管取得了这些进展，但特定市场的复杂性和持续的监管变化构成了瓶颈，需要积极适应和提高技能。了解这些市场动态需要对政策趋势保持敏感，有效回应监管要求，并加快策略回应以确保竞争力。

主要市场统计
基准年[2023] 156.3亿美元
预测年份 [2024] 172.2亿美元
预测年份 [2030] 317.1亿美元
复合年增长率（%） 10.63%

市场动态：揭示快速发展的监管事务市场的关键市场洞察

供需的动态交互作用正在改变监管事务市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 全球药物发现与开发显着成长
    • 医疗保健产业政府法规的变化
    • 罕见疾病增加和新感染疾病出现
  • 市场限制因素
    • 提供医药服务的成本高昂
  • 市场机会
    • 主要市场参与者大力投资开拓医疗保健设备
    • 消费者对生技药品和学名药的偏好日益增长
  • 市场挑战
    • 严格的政府政策和与监管事务相关的政策规定

波特五力：驾驭监管事务市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解监理事务市场的外部影响

外部宏观环境因素在塑造监管事务市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解监理事务市场的竞争格局

监管事务市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵监理事务市场供应商绩效评估

FPNV 定位矩阵是评估监理事务市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议 规划您在监理事务市场的成功之路

对于希望加强在全球市场的影响力的公司来说，监管事务市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球药物发现与开发显着成长
      • 医疗保健领域政府法规环境的变化
      • 罕见疾病增加和新感染疾病出现
    • 抑制因素
      • 提供监管服务的成本高昂
    • 机会
      • 主要市场参与者对医疗保健设备开发的巨额投资
      • 消费者对生物製药和学名药的偏好日益增长
    • 任务
      • 与监管事务相关的严格政府政策和法规
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 监理事务市场：依服务分类

  • 法律代表
  • 产品註册及临床试验申请
  • 监理咨询
  • 撰写和发布规范文件

第七章 监管事务市场（依指标）

  • 心臟病学
  • 免疫学
  • 神经病学
  • 肿瘤学

第八章 监理事务市场：依阶段

  • 临床研究
  • 临床前

第九章 监理事务市场：依类别

  • 生物製药
    • 生物相似药
    • 生物技术
  • 药品
    • 非专利的
    • 创新者
  • 医疗设备
    • 诊断
    • 治疗药物

第十章服务供应商监管事务市场

  • 公司内部
  • 外包

第十一章 按公司规模分類的监管事务市场

  • 大的
  • 中等的
  • 小的

第十二章 监理事务市场：依最终用途分类

  • 生技公司
  • 医疗设备公司
  • 製药公司

第十三章美洲监理事务市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十四章亚太监管事务市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十五章 欧洲、中东和非洲监管事务市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十六章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Asphalion, SL
  • Cambridge Regulatory Services
  • Charles River Laboratories, Inc.
  • Clinilabs Inc.
  • Educo Life Sciences Ltd
  • Exalon GmbH
  • Genpact Ltd.
  • ICON PLC
  • IQVIA Holdings Inc.
  • Laboratory Corporation of America Holdings
  • Medpace Inc.
  • NDA Group AB
  • Pharmalex GMBH
  • Qvigilance
  • WuXi AppTec Co. Ltd.
Product Code: MRR-0D217D5AEA5B

The Regulatory Affairs Market was valued at USD 15.63 billion in 2023, expected to reach USD 17.22 billion in 2024, and is projected to grow at a CAGR of 10.63%, to USD 31.71 billion by 2030.

The scope of regulatory affairs within the market research domain involves ensuring compliance with laws and regulations to protect public health and safety, overseeing product lifecycle management, and facilitating approvals and registrations across various industries such as pharmaceuticals, biotechnology, medical devices, and food services. The necessity of regulatory affairs lies in its role in safeguarding public interests, reducing risks, and maintaining market access while bolstering company credibility. This discipline's applications range from strategic advice in early product development stages to post-market surveillance and regulatory submissions. End-use extends to sectors focused on product efficacy, safety, and standard adherence. Key growth influencers include evolving regulatory landscapes, increasing product complexity, and globalization encouraging cross-border market penetration. A surge in digitization has opened avenues for streamlining regulatory processes through automation and AI, presenting fresh opportunities for companies to reduce time-to-market while improving compliance accuracy. However, these developments also bring challenges such as dealing with constantly changing global regulations and the high costs associated with meeting diverse compliance requirements. Market players must innovate in collecting and analyzing regulatory data, adopting predictive analysis, and leveraging digital transformation to remain competitive. Companies should navigate potential opportunities by investing in technologies that enhance data transparency, engage in proactive stakeholder collaboration, and employ agile methodologies in regulatory submissions. Innovation can also be fostered by focusing on building robust systems that offer real-time regulatory intelligence and insights, which stand to revolutionize risk assessment and decision-making processes. Despite these strides, the market's inherent complexity and continuous regulatory amendments can create bottlenecks, demanding proactive adaptation and skills enhancement. Understanding these market dynamics requires a keen awareness of policy trends, leading to accelerated, strategic responses in meeting regulatory demands efficiently, securing a competitive edge.

KEY MARKET STATISTICS
Base Year [2023] USD 15.63 billion
Estimated Year [2024] USD 17.22 billion
Forecast Year [2030] USD 31.71 billion
CAGR (%) 10.63%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Regulatory Affairs Market

The Regulatory Affairs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Significant growth in drug discovery and development worldwide
    • Changing governmental regulatory landscapes for healthcare sector
    • Rising prevalence of rare disorders and emergence of novel infectious diseases
  • Market Restraints
    • High cost of delivering regulatory services
  • Market Opportunities
    • Massive investments by the key market players for development of healthcare equipment
    • Increasing consumer preference for biologics and generic drugs
  • Market Challenges
    • Stringent governmental policies and regulations associated with regulatory affairs

Porter's Five Forces: A Strategic Tool for Navigating the Regulatory Affairs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Regulatory Affairs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Regulatory Affairs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Regulatory Affairs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Regulatory Affairs Market

A detailed market share analysis in the Regulatory Affairs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Regulatory Affairs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Regulatory Affairs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Regulatory Affairs Market

A strategic analysis of the Regulatory Affairs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Regulatory Affairs Market, highlighting leading vendors and their innovative profiles. These include Asphalion, S.L., Cambridge Regulatory Services, Charles River Laboratories, Inc., Clinilabs Inc., Educo Life Sciences Ltd, Exalon GmbH, Genpact Ltd., ICON PLC, IQVIA Holdings Inc., Laboratory Corporation of America Holdings, Medpace Inc., NDA Group AB, Pharmalex GMBH, Qvigilance, and WuXi AppTec Co. Ltd..

Market Segmentation & Coverage

This research report categorizes the Regulatory Affairs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Services, market is studied across Legal Representation, Product Registration & Clinical Trial Applications, Regulatory Consulting, and Regulatory Writing & Publishing.
  • Based on Indication, market is studied across Cardiology, Immunology, Neurology, and Oncology.
  • Based on Stage, market is studied across Clinical Studies and Preclinical.
  • Based on Category, market is studied across Biologics, Drugs, and Medical Devices. The Biologics is further studied across Biosimilars and Biotech. The Drugs is further studied across Generics and Innovator. The Medical Devices is further studied across Diagnostics and Therapeutics.
  • Based on Service Provider, market is studied across In-House and Outsourced.
  • Based on Company Size, market is studied across Large, Medium, and Small.
  • Based on End-Use, market is studied across Biotechnology Companies, Medical Device Companies, and Pharmaceutical Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Significant growth in drug discovery and development worldwide
      • 5.1.1.2. Changing governmental regulatory landscapes for healthcare sector
      • 5.1.1.3. Rising prevalence of rare disorders and emergence of novel infectious diseases
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of delivering regulatory services
    • 5.1.3. Opportunities
      • 5.1.3.1. Massive investments by the key market players for development of healthcare equipment
      • 5.1.3.2. Increasing consumer preference for biologics and generic drugs
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent governmental policies and regulations associated with regulatory affairs
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Regulatory Affairs Market, by Services

  • 6.1. Introduction
  • 6.2. Legal Representation
  • 6.3. Product Registration & Clinical Trial Applications
  • 6.4. Regulatory Consulting
  • 6.5. Regulatory Writing & Publishing

7. Regulatory Affairs Market, by Indication

  • 7.1. Introduction
  • 7.2. Cardiology
  • 7.3. Immunology
  • 7.4. Neurology
  • 7.5. Oncology

8. Regulatory Affairs Market, by Stage

  • 8.1. Introduction
  • 8.2. Clinical Studies
  • 8.3. Preclinical

9. Regulatory Affairs Market, by Category

  • 9.1. Introduction
  • 9.2. Biologics
    • 9.2.1. Biosimilars
    • 9.2.2. Biotech
  • 9.3. Drugs
    • 9.3.1. Generics
    • 9.3.2. Innovator
  • 9.4. Medical Devices
    • 9.4.1. Diagnostics
    • 9.4.2. Therapeutics

10. Regulatory Affairs Market, by Service Provider

  • 10.1. Introduction
  • 10.2. In-House
  • 10.3. Outsourced

11. Regulatory Affairs Market, by Company Size

  • 11.1. Introduction
  • 11.2. Large
  • 11.3. Medium
  • 11.4. Small

12. Regulatory Affairs Market, by End-Use

  • 12.1. Introduction
  • 12.2. Biotechnology Companies
  • 12.3. Medical Device Companies
  • 12.4. Pharmaceutical Companies

13. Americas Regulatory Affairs Market

  • 13.1. Introduction
  • 13.2. Argentina
  • 13.3. Brazil
  • 13.4. Canada
  • 13.5. Mexico
  • 13.6. United States

14. Asia-Pacific Regulatory Affairs Market

  • 14.1. Introduction
  • 14.2. Australia
  • 14.3. China
  • 14.4. India
  • 14.5. Indonesia
  • 14.6. Japan
  • 14.7. Malaysia
  • 14.8. Philippines
  • 14.9. Singapore
  • 14.10. South Korea
  • 14.11. Taiwan
  • 14.12. Thailand
  • 14.13. Vietnam

15. Europe, Middle East & Africa Regulatory Affairs Market

  • 15.1. Introduction
  • 15.2. Denmark
  • 15.3. Egypt
  • 15.4. Finland
  • 15.5. France
  • 15.6. Germany
  • 15.7. Israel
  • 15.8. Italy
  • 15.9. Netherlands
  • 15.10. Nigeria
  • 15.11. Norway
  • 15.12. Poland
  • 15.13. Qatar
  • 15.14. Russia
  • 15.15. Saudi Arabia
  • 15.16. South Africa
  • 15.17. Spain
  • 15.18. Sweden
  • 15.19. Switzerland
  • 15.20. Turkey
  • 15.21. United Arab Emirates
  • 15.22. United Kingdom

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2023
  • 16.2. FPNV Positioning Matrix, 2023
  • 16.3. Competitive Scenario Analysis
  • 16.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Asphalion, S.L.
  • 2. Cambridge Regulatory Services
  • 3. Charles River Laboratories, Inc.
  • 4. Clinilabs Inc.
  • 5. Educo Life Sciences Ltd
  • 6. Exalon GmbH
  • 7. Genpact Ltd.
  • 8. ICON PLC
  • 9. IQVIA Holdings Inc.
  • 10. Laboratory Corporation of America Holdings
  • 11. Medpace Inc.
  • 12. NDA Group AB
  • 13. Pharmalex GMBH
  • 14. Qvigilance
  • 15. WuXi AppTec Co. Ltd.

LIST OF FIGURES

  • FIGURE 1. REGULATORY AFFAIRS MARKET RESEARCH PROCESS
  • FIGURE 2. REGULATORY AFFAIRS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL REGULATORY AFFAIRS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 19. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 23. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 27. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 28. REGULATORY AFFAIRS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 29. REGULATORY AFFAIRS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. REGULATORY AFFAIRS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL REGULATORY AFFAIRS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. REGULATORY AFFAIRS MARKET DYNAMICS
  • TABLE 7. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY LEGAL REPRESENTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY PRODUCT REGISTRATION & CLINICAL TRIAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY REGULATORY CONSULTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY REGULATORY WRITING & PUBLISHING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY CLINICAL STUDIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY PRECLINICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY BIOSIMILARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY BIOTECH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY GENERICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY INNOVATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY IN-HOUSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY OUTSOURCED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY LARGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY MEDIUM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY SMALL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 74. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 82. CANADA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 83. CANADA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 84. CANADA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 88. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 90. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 91. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 92. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 93. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 94. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 117. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 118. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 120. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 121. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 122. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 124. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 126. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 127. CHINA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 128. CHINA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. CHINA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 130. CHINA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 131. CHINA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 132. CHINA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 133. CHINA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 134. CHINA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 135. CHINA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 136. CHINA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. INDIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 138. INDIA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 139. INDIA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 140. INDIA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 141. INDIA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 142. INDIA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 143. INDIA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 144. INDIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 145. INDIA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 146. INDIA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 147. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 148. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 149. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 150. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 151. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 152. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 153. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 154. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 155. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 156. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 157. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 158. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 159. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 160. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 161. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 162. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 163. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 164. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 165. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 166. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 167. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 168. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 169. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 170. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 171. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 172. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 173. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 174. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 175. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 176. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 177. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 178. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 179. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 180. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 181. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 182. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 183. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 184. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 185. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 186. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 187. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 188. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 189. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 190. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 191. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 192. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 193. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 194. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 195. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 196. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 197. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 207. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 208. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 209. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 210. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 211. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 212. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 213. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 214. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 215. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 216. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 217. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 218. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 219. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 220. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 221. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 222. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 223. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 224. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 225. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 226. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 227. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 228. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 229. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 230. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 231. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 232. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 233. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 234. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 235. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 236. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 248. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 249. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 250. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 251. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 252. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 253. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 254. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 255. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 256. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 257. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 258. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 259. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 260. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 261. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 262. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 263. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 264. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 265. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 266. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 267. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 268. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 269. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 270. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 271. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 272. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 273. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 274. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 275. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 276. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 277. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 278. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 279. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 280. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 281. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 282. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 283. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 284. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 285. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 286. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 287. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 288. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 289. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 290. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 291. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 292. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 293. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 294. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 295. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 296. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 297. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 298. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 299. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 300. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 301. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 302. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 303. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 304. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 305. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 306. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 307. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 308. ITALY REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 309. ITALY REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 310. ITALY REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 311. ITALY REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 312. ITALY REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 313. ITALY REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 314. ITALY REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 315. ITALY REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 316. ITALY REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 317. ITALY REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 318. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 319. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 320. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 321. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 322. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 323. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 324. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 325. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 326. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 327. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 328. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 329. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 330. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 331. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 332. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 333. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 334. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 335. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 336. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 337. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 338. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 339. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 340. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 341. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 342. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 343. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 344. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 345. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 346. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 347. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 348. POLAND REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 349. POLAND REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 350. POLAND REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 351. POLAND REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 352. POLAND REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 353. POLAND REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 354. POLAND REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 355. POLAND REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 356. POLAND REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 357. POLAND REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 358. QATAR REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 359. QATAR REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 360. QATAR REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 361. QATAR REG